165 related articles for article (PubMed ID: 28940159)
1. Zinc Status in Beta Thalassemia Major Patients.
Karunaratna AMDS; Ranasingha JGS; Mudiyanse RM
Biol Trace Elem Res; 2018 Jul; 184(1):1-6. PubMed ID: 28940159
[TBL] [Abstract][Full Text] [Related]
2. Zinc status in patients with major beta-thalassemia.
Mehdizadeh M; Zamani G; Tabatabaee S
Pediatr Hematol Oncol; 2008; 25(1):49-54. PubMed ID: 18231954
[TBL] [Abstract][Full Text] [Related]
3. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
[TBL] [Abstract][Full Text] [Related]
4. Immunological evaluation of β-thalassemia major patients receiving oral iron chelator deferasirox.
Aleem A; Shakoor Z; Alsaleh K; Algahtani F; Iqbal Z; Al-Momen A
J Coll Physicians Surg Pak; 2014 Jul; 24(7):467-71. PubMed ID: 25052967
[TBL] [Abstract][Full Text] [Related]
5. Ocular abnormalities in multi-transfused beta-thalassemia patients.
Jafari R; Heydarian S; Karami H; Shektaei MM; Dailami KN; Amiri AA; Rezaee MR; Far AA
Indian J Ophthalmol; 2015 Sep; 63(9):710-5. PubMed ID: 26632126
[TBL] [Abstract][Full Text] [Related]
6. Acute Effects of Blood Transfusion on Insulin Sensitivity and Pancreatic β-Cell Function in Children with β-Thalassemia/Hemoglobin E Disease.
Wankanit S; Chuansumrit A; Poomthavorn P; Khlairit P; Pongratanakul S; Mahachoklertwattana P
J Clin Res Pediatr Endocrinol; 2018 Mar; 10(1):1-7. PubMed ID: 28739553
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
[TBL] [Abstract][Full Text] [Related]
8. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
10. Short stature and truncal shortening in transfusion dependent thalassemia patients: results from a thalassemia center in Malaysia.
Hamidah A; Rahmah R; Azmi T; Aziz J; Jamal R
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):625-30. PubMed ID: 11944728
[TBL] [Abstract][Full Text] [Related]
11. Growth impairment in beta-thalassemia major: the role of trace element deficiency and other potential factors.
Eshghi P; Alavi S; Ghavami S; Rashidi A
J Pediatr Hematol Oncol; 2007 Jan; 29(1):5-8. PubMed ID: 17230059
[TBL] [Abstract][Full Text] [Related]
12. Blunted serum erythropoietin response to anemia in patients polytransfused for beta-thalassemia major.
Chen JS; Lin KH; Wang ST; Tsao CJ; Yeh TF
J Pediatr Hematol Oncol; 1998; 20(2):140-4. PubMed ID: 9544165
[TBL] [Abstract][Full Text] [Related]
13. The Zinc and Copper Levels in Thalassemia Major Patients, Receiving Iron Chelation Therapy.
Zekavat OR; Bahmanjahromi A; Haghpanah S; Ebrahimi S; Cohan N
J Pediatr Hematol Oncol; 2018 Apr; 40(3):178-181. PubMed ID: 29420373
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients.
Al-Awadhi AM; Alfadhli SM; Al-Khaldi D; Borhama M; Borusly M
Int J Lab Hematol; 2010 Apr; 32(2):191-6. PubMed ID: 19453575
[TBL] [Abstract][Full Text] [Related]
15. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
17. Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: An Egyptian center experience.
Sherief LM; Abd El-Salam SM; Kamal NM; El Safy O; Almalky MA; Azab SF; Morsy HM; Gharieb AF
Biomed Res Int; 2014; 2014():261761. PubMed ID: 24812610
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular diastolic abnormalities in children with beta-thalassemia major: a Doppler echocardiographic study.
Yaprak I; Akşit S; Oztürk C; Bakiler AR; Dorak C; Türker M
Turk J Pediatr; 1998; 40(2):201-9. PubMed ID: 9677725
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of some essential element levels in thalassemia major patients in Mosul district, Iraq.
Al-Samarrai AH; Adaay MH; Al-Tikriti KA; Al-Anzy MM
Saudi Med J; 2008 Jan; 29(1):94-7. PubMed ID: 18176681
[TBL] [Abstract][Full Text] [Related]
20. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
Hagag AA; Elgamasy MA; Abd Elbar ES
Egypt J Immunol; 2016 Jan; 23(1):97-105. PubMed ID: 28502157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
